These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27394653)

  • 1. Predictive value of low serum pancreatic enzymes in invasive intraductal papillary mucinous neoplasms.
    Yagi Y; Masuda A; Zen Y; Takenaka M; Toyama H; Sofue K; Shiomi H; Kobayashi T; Nakagawa T; Yamanaka K; Hoshi N; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
    Pancreatology; 2016; 16(5):893-9. PubMed ID: 27394653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms.
    Roch AM; Parikh JA; Al-Haddad MA; DeWitt JM; Ceppa EP; House MG; Nakeeb A; Schmidt CM
    Surgery; 2014 Oct; 156(4):923-9. PubMed ID: 25239347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of pancreatic calcification on preoperative computed tomography of intraductal papillary mucinous neoplasms.
    Tsujimae M; Masuda A; Shiomi H; Toyama H; Sofue K; Ueshima E; Yamakawa K; Ashina S; Yamada Y; Tanaka T; Tanaka S; Nakano R; Sato Y; Ikegawa T; Kurosawa M; Fujigaki S; Kobayashi T; Sakai A; Kutsumi H; Zen Y; Itoh T; Fukumoto T; Kodama Y
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1648-1655. PubMed ID: 31111533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic inflammation and atrophy are not associated with pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
    Yagi Y; Masuda A; Zen Y; Shiomi H; Toyama H; Sofue K; Takenaka M; Kobayashi T; Nakagawa T; Yamanaka K; Ikegawa T; Hoshi N; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
    Pancreatology; 2018 Jan; 18(1):54-60. PubMed ID: 29269290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum SPan-1 and lymph node metastasis in invasive intraductal papillary mucinous neoplasm of the pancreas.
    Yamanaka K; Masuda A; Toyama H; Shiomi H; Zen Y; Sofue K; Takenaka M; Kobayashi T; Sakai A; Yagi Y; Nakagawa T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
    Pancreatology; 2017; 17(1):123-129. PubMed ID: 27979602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis in intraductal papillary mucinous neoplasms correlates with pancreatic volume and epithelial subtypes.
    Tanaka T; Masuda A; Sofue K; Toyama H; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
    Pancreatology; 2021 Jan; 21(1):138-143. PubMed ID: 33328127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated papilla with mucin extrusion is a potential predictor of acute pancreatitis associated with intraductal papillary mucinous neoplasms of pancreas.
    Hata T; Sakata N; Okada T; Aoki T; Motoi F; Katayose Y; Egawa S; Unno M
    Pancreatology; 2013; 13(6):615-20. PubMed ID: 24280579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcifying obstructive pancreatitis: a study of intraductal papillary mucinous neoplasm associated with pancreatic calcification.
    Zapiach M; Yadav D; Smyrk TC; Fletcher JG; Pearson RK; Clain JE; Farnell MB; Chari ST
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):57-63. PubMed ID: 15017633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric and morphological analysis of intraductal papillary mucinous neoplasm of the pancreas using computed tomography and magnetic resonance imaging.
    Murayama S; Kimura W; Hirai I; Takasu N; Takeshita A; Moriya T
    Pancreas; 2011 Aug; 40(6):876-82. PubMed ID: 21747312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma.
    Kawamoto S; Lawler LP; Horton KM; Eng J; Hruban RH; Fishman EK
    AJR Am J Roentgenol; 2006 Mar; 186(3):687-95. PubMed ID: 16498096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
    Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
    J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasms (IPMN) of the pancreas: clinico-pathologic results.
    Cienfuegos JA; Rotellar F; Martí-Cruchaga P; Valentí V; Zozaya G; Bueno A; Pedano N; Lozano MD; Sola JJ; Pardo F
    Rev Esp Enferm Dig; 2010 May; 102(5):314-20. PubMed ID: 20524759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN).
    Arnelo U; Siiki A; Swahn F; Segersvärd R; Enochsson L; del Chiaro M; Lundell L; Verbeke CS; Löhr JM
    Pancreatology; 2014; 14(6):510-4. PubMed ID: 25287157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.